Detalhe da pesquisa
1.
Effectiveness and safety of glecaprevir/pibrentasvir for 8 weeks in the treatment of patients with acute hepatitis C: A single-arm retrospective study.
Hepatology
; 2024 May 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38768260
2.
Efficacy and safety of glecaprevir/pibrentasvir in treatment-naïve adults with chronic hepatitis C virus genotypes 1-6 in Brazil.
Ann Hepatol
; 20: 100257, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-32949786
3.
Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection.
Clin Gastroenterol Hepatol
; 18(11): 2544-2553.e6, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32621971
4.
Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies.
Liver Int
; 40(10): 2385-2393, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32445613
5.
Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial.
JAMA
; 313(12): 1223-31, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25706092
6.
Evaluation of myocardial infarction and coronary artery disease in subjects taking lopinavir/ritonavir: a study using clinical trial and pharmacovigilance databases.
Int J Clin Pharmacol Ther
; 50(6): 391-402, 2012 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-22541744
7.
Diarrhea associated with lopinavir/ritonavir-based therapy: results of a meta-analysis of 1469 HIV-1-infected participants.
J Int Assoc Physicians AIDS Care (Chic)
; 11(4): 252-9, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22544446
8.
Bring Blood Glucose Down! An intervention to reduce fear of hypoglycemia in caregivers of adolescents with type 1 diabetes: Study design and participant characteristics.
Contemp Clin Trials
; 118: 106792, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35589025
9.
Examination of noninferiority, safety, and tolerability of lopinavir/ritonavir and raltegravir compared with lopinavir/ritonavir and tenofovir/ emtricitabine in antiretroviral-naïve subjects: the progress study, 48-week results.
HIV Clin Trials
; 12(5): 255-67, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-22180523
10.
The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children.
J Allergy Clin Immunol
; 126(2): 256-62, 2010 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-20624638
11.
Efficacy and Safety of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C: A Pooled Analysis of Five Phase II/III Trials.
Gut Liver
; 15(6): 895-903, 2021 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34053916
12.
Glecaprevir-pibrentasvir to treat chronic hepatitis C virus infection in Asia: two multicentre, phase 3 studies- a randomised, double-blind study (VOYAGE-1) and an open-label, single-arm study (VOYAGE-2).
Lancet Gastroenterol Hepatol
; 5(9): 839-849, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32682494
13.
Geographic and temporal trends of transmitted HIV-1 drug resistance among antiretroviral-naïve subjects screening for two clinical trials in North America and Western Europe.
HIV Clin Trials
; 10(2): 94-103, 2009.
Artigo
Inglês
| MEDLINE | ID: mdl-19487179
14.
Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1-6 receiving opioid substitution therapy.
Int J Drug Policy
; 66: 73-79, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30735896
15.
Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing.
J Pediatr
; 151(1): 34-42, 42.e1, 2007 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-17586188
16.
Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2.
Open Forum Infect Dis
; 4(3): ofx154, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28948180
17.
Safety and efficacy of ombitasvir - 450/r and dasabuvir and ribavirin in HCV/HIV-1 co-infected patients receiving atazanavir or raltegravir ART regimens.
J Int AIDS Soc
; 17(4 Suppl 3): 19500, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25394009
18.
Lopinavir/ritonavir combined with raltegravir or tenofovir/emtricitabine in antiretroviral-naive subjects: 96-week results of the PROGRESS study.
AIDS Res Hum Retroviruses
; 29(2): 256-65, 2013 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-22730929
19.
Efficacy and safety of paritaprevir/ritonavir/ombitasvir combined with dasabuvir in non-cirrhotic Asian adult patients with newly diagnosed and treated chronic HCV genotype 1b infection: a randomized, double-blind, placebo-controlled study - China data / 中华肝脏病杂志
Chinese Journal of Hepatology
; (12): 359-364, 2018.
Artigo
Chinês
| WPRIM | ID: wpr-806560
20.
Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir combined with ribavirin in Asian adult patients with chronic HCV genotype 1b infection and compensated cirrhosis / 中华肝脏病杂志
Chinese Journal of Hepatology
; (12): 353-358, 2018.
Artigo
Chinês
| WPRIM | ID: wpr-806559